These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9529649)

  • 21. Management of fever without source in infants and children.
    Baraff LJ
    Ann Emerg Med; 2000 Dec; 36(6):602-14. PubMed ID: 11097701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The challenge of changing the inactivated poliomyelitis vaccine in Latin America: declaration of the Latin American Society of Pediatric Infectious Diseases (SLIPE).
    Falleiros-Arlant LH; Avila-Agüero ML; Brea del Castillo J; Mariño C
    Rev Chilena Infectol; 2014 Oct; 31(5):590-603. PubMed ID: 25491459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Management of fever without source in children].
    Iwańczak B; Pytrus T; Stawarski A; Mowszet K; Iwańczak F
    Przegl Lek; 2007; 64 Suppl 3():20-4. PubMed ID: 18431906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coverage estimates and patterns of inactivated poliovirus vaccine (IPV) use prior to and during the polio eradication endgame, Jinan City, China, 2010-2015.
    Chang C; Zhang J; Zhou J; Cao R; Song K; Liu C; Zhang X; Geng X; Liu X; Li C
    Hum Vaccin Immunother; 2016 Nov; 12(11):2749-2752. PubMed ID: 27437792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The prevention of early-onset neonatal group B streptococcal disease.
    Money D; Allen VM;
    J Obstet Gynaecol Can; 2013 Oct; 35(10):939-948. PubMed ID: 24165063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prospects for the eradication of infectious diseases.
    Stuart-Harris C
    Rev Infect Dis; 1984; 6(3):405-11. PubMed ID: 6377445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practice guidelines for management of infants and children with fever without source (FWS).
    Hupert J
    Pediatrics; 1994 Feb; 93(2):347; author reply 349-51. PubMed ID: 8121760
    [No Abstract]   [Full Text] [Related]  

  • 29. Pediatric infectious disease emergencies.
    Harper MB
    Curr Opin Pediatr; 1995 Jun; 7(3):302-8. PubMed ID: 7663618
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Practice guidelines for management of infants and children with fever without source (FWS).
    Kokx NP
    Pediatrics; 1994 Feb; 93(2):347-8; author reply 349-51. PubMed ID: 8121761
    [No Abstract]   [Full Text] [Related]  

  • 31. Neutralising antibody response to oral poliovirus vaccine after primary immunisation with inactivated poliovirus vaccine.
    Guérin N; Bregère P; Caudrelier P; Raynaud O
    Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):815-6. PubMed ID: 9923532
    [No Abstract]   [Full Text] [Related]  

  • 32. Aetiology and management of children with acute fever of unknown origin.
    Akpede GO; Akenzua GI
    Paediatr Drugs; 2001; 3(3):169-93. PubMed ID: 11310716
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pediatric clinical evaluation and pneumonia.
    McCarthy PL
    Curr Opin Pediatr; 1996 Oct; 8(5):427-9. PubMed ID: 8946119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
    O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
    Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of universal antenatal screening for group B streptococcus.
    Van Dyke MK; Phares CR; Lynfield R; Thomas AR; Arnold KE; Craig AS; Mohle-Boetani J; Gershman K; Schaffner W; Petit S; Zansky SM; Morin CA; Spina NL; Wymore K; Harrison LH; Shutt KA; Bareta J; Bulens SN; Zell ER; Schuchat A; Schrag SJ
    N Engl J Med; 2009 Jun; 360(25):2626-36. PubMed ID: 19535801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practice guidelines for management of infants and children with fever without source (FWS).
    Lehmann HP; Andrews J
    Pediatrics; 1994 Feb; 93(2):345-6; author reply 349-51. PubMed ID: 8121757
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
    Moĭseieva HV; Zadorozhna VI
    Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in neonatal infections.
    Larson E
    J Obstet Gynecol Neonatal Nurs; 1987; 16(6):404-9. PubMed ID: 3320299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poliomyelitis prevention: recommendations for use of inactivated poliovirus vaccine and live oral poliovirus vaccine. American Academy of Pediatrics Committee on Infectious Diseases.
    Pediatrics; 1997 Feb; 99(2):300-5. PubMed ID: 9024465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Practice guidelines for management of infant and children with fever without source (FWS).
    Falk HL
    Pediatrics; 1994 Feb; 93(2):347; author reply 349-51. PubMed ID: 8121759
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.